Scenario: A dispute erupts (title to shares, side‑deals, valuation, or payout mechanics). Street wins (or seeks) urgent New York–seat arbitration relief, but the founder, buyer, or a creditor runs to local courts (Delaware/Offshore/buyer seat) to stall, ignore, or undermine it. Risk: the deal clock runs out, shares get moved, or proceeds get trapped because an order isn’t recognized fast enough.

Jurisdictions: Delaware (OpCo), Offshore (SPV), Switzerland (likely buyer seat)

Street Constraints: tokens not securities; no contractual profit/dividend rights; resource allocations are discretionary via DAO; founders keep operating control; independent co‑sign governance.

Owner / Date / Pass‑Fail: Lukas / 2025‑09‑07 / Pending

Related prior stress‑tests to lean on:

S#01 (NY arbitration + TA “final order” & dual‑key) S#02 (BK trustee & cross‑seat pause/true‑sale evidence) S#03 (cap‑snapshot/notice mechanics) S#04 (buyer acknowledgments; stockholder‑rep; snapshot) S#05 (fair‑value, expert determination, no‑leakage) S#07 (expert fast‑track; escrow discipline) S#08 (independent co‑sign + reserved matters)

Problem

Arbitration or court relief in one place doesn’t automatically move shares, unlock cash, or bind third parties elsewhere. A bad actor can forum‑shop, get an ex parte order, or simply run out the clock while you try to mirror/enforce your award across seats. The result can be frozen closings, registrar confusion, or cash stuck in escrow.

Legal Vulnerabilities

• Seat / law fragmentation: Different governing laws and a New York arbitral seat, but no explicit mirror‑order playbook or consent‑to‑injunctions in Delaware/Offshore/buyer seat. (We’ve used NY seat widely in S#01/S#06.)
• Emergency relief gap: Arbitration clause lacks an emergency arbitrator + wording that TA/custodian will treat emergency orders as binding for “status‑quo” actions (re‑registration freezes, escrow holds). S#01 expects “final, non‑appealable order” at the TA, which can be too slow mid‑crisis.
• Non‑signatory choke points: TA/custodian/buyer are not bound to honor arbitral directions; no pre‑signed acknowledgments. (S#01/S#08 show dual‑key + independence, but add third‑party adherence.)
• Parallel proceedings: No anti‑suit/anti‑anti‑suit strategy; parties race to local courts to block enforcement or seek declarations. (S#04 shows buyer leverage around “clean cap.”)
• Service/apostille friction: No agent for service in each seat; missing apostille/translation package slows recognition.
• Insolvency stay risk: U.S. or foreign BK filings can stay arbitration/enforcement steps (S#02).
• Escrow inertia: SPA escrows lack “recognize NY award → release” language; buyer seat courts prefer local tests (S#05/S#07).

Regulatory Risks

If resource allocations continue while enforcement is disputed, regulators/class actions can allege misrepresentation (“you said the equity/allocations were fine”). Prior tests instruct auto‑pause on disputes/inquiries.

Market Precedents (what we learned in earlier tests)

• Work when you look “normal”: Present one clean shareholder (SPV), keep tokenholders outside buyer’s legal perimeter (S#04).